Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens.
Maurer
J R
JR
Toronto Lung Transplant Program, University of Toronto, Ontario, Canada.
Snell
G
G
deHoyos
A
A
Kesten
S
S
Winton
T
T
D000206:Actuarial Analysis; D000212:Acyclovir / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003587:Cytomegalovirus; D003586:Cytomegalovirus Infections / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D016040:Lung Transplantation; D016019:Survival Analysis; D016896:Treatment Outcome
D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C045781:cytomegalovirus-specific hyperimmune globulin; D000212:Acyclovir